SEC Comment Letter 0000000000-24-002545 to GeoVax Labs, Inc. (GOVX)
GeoVax Labs, Inc.
Date: March 7, 2024 · CIK: 0000832489 · Accession: 0000000000-24-002545
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-277585
Letter
United States securities and exchange commission logo March 7, 2024 David A. Dodd President & Chief Executive Officer GeoVax Labs, Inc. 1900 Lake Park Drive, Suite 380 Smyrna, Georgia 30080 Re:GeoVax Labs, Inc. Registration Statement on Form S-3 Filed March 1, 2024 File No. 333-277585 Dear David A. Dodd: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: F. Reid Avett, Esq.
Show Raw Text
United States securities and exchange commission logo
March 7, 2024
David A. Dodd
President & Chief Executive Officer
GeoVax Labs, Inc.
1900 Lake Park Drive, Suite 380
Smyrna, Georgia 30080
Re:GeoVax Labs, Inc.
Registration Statement on Form S-3
Filed March 1, 2024
File No. 333-277585
Dear David A. Dodd:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: F. Reid Avett, Esq.